SunOpta director awarded 3,248 STKL shares
SunOpta Inc. director Hollis Richard Dean acquired 3,248 common shares of SunOpta on February 9, 2026, at a reported price of $6.39 per share.
Rhea-AI Filing Summary
SunOpta Inc. director Hollis Richard Dean acquired 3,248 common shares of SunOpta on February 9, 2026, at a reported price of $6.39 per share. The shares were issued in lieu of cash for his service on the board of directors.
Following this stock award, Dean directly holds 586,665 SunOpta common shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 3,248 shares
Grant/Award
1 txn
Insider
Hollis Richard Dean
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares | 3,248 | $6.39 | $21K |
Holdings After Transaction:
Common Shares — 586,665 shares (Direct)
Footnotes (1)
- F1. The shares were issued in lieu of cash to the reporting person for service on the board of directors.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did SunOpta (STKL) disclose for Hollis Richard Dean?
SunOpta disclosed that director Hollis Richard Dean acquired 3,248 common shares on February 9, 2026. The shares were granted as a stock award in lieu of cash compensation for his board service, increasing his direct holdings to 586,665 shares.
Was the SunOpta (STKL) Form 4 transaction a market purchase or an award?
The SunOpta Form 4 shows the transaction as an acquisition coded “A,” described as a grant, award, or other acquisition. Footnotes clarify the 3,248 shares were issued in lieu of cash, indicating non-cash director compensation rather than an open-market share purchase.
What does transaction code “A” mean in the SunOpta (STKL) Form 4 filing?
In the SunOpta Form 4, transaction code “A” stands for “grant, award, or other acquisition.” It indicates the 3,248 shares reported for Hollis Richard Dean were received as a stock award, not bought or sold in a regular open-market transaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.